Bundlers, Lobbyists, and Access: What Studies Show About Big-Money Influence
Recent academic studies have found that large contributions do work to ensure access for corporate lobbyists and that fundraising influences key committee assignments.
Influence
Page 12
Here Are the Lobbyists and Corporate Execs Collecting Checks for Pete Buttigieg
As the Buttigieg campaign stops releasing its bundler names and blocks press from fundraising events, here are some of the pharmaceutical and finance executives behind its rise in the big money race, and three attorneys whose donations were returned.
McKinsey Employees Open Their Wallets for Alumnus Pete Buttigieg
Executives from the consulting firm’s energy, banking, and health care practices have maxed out to Mayor Pete's presidential campaign.
McConnell Accelerates Judicial Confirmations After Taking a Quarter Million from Prominent Conservative Legal Activist
Federalist Society board member and Committee for Justice founder C. Boyden Gray recently gave his largest contribution ever to McConnell’s joint fundraising committee.
ExxonMobil Is Still Bankrolling Climate Science Deniers
A review of the company's latest grantmaking report shows the company made large donations to groups, think tanks, and business associations that reject the reality and seriousness of the climate crisis
The Business of Homelessness: NYC’s Biggest Shelter Contractor Makes Millions, Offers Shoddy Facilities
As residents complain of maintenance, supply, and safety issues, Acacia Network’s politically connected executives bring home hefty salaries and face a self-dealing investigation.
The Sludgy Career of Kurt Volker
The special envoy to Ukraine tried to have it both ways: Trump hatchet man and honorable public servant. He failed at both.
Shadow Lobbyist Crowley to Raise Money for Kennedy’s Race Against Green New Deal Chief Sponsor
Crowley is one of several revolving-door influence peddlers who will host an upcoming fundraiser for Kennedy.
Out With ALEC, In With Corporations Writing Their Own Laws
As the corporate bill mill wanes in influence, large businesses are taking matters into their own hands.
After Taking $1 Million from Big Pharma, Hoyer Says Marijuana is a Gateway Drug
Hoyer’s belief that marijuana “leads to the use of harder, very harmful drugs” has been thoroughly debunked.